PEPTIDE

Ipamorelin

Ipamorelin is a selective pentapeptide growth hormone secretagogue (GHRP) that activates the GHS-R1a (ghrelin) receptor to stimulate physiological pulsatile growth hormone (GH) release. Unlike older GHRPs, it does not elevate cortisol, ACTH, prolactin, or appetite, making it the most selective GH-releasing peptide for metabolic and body composition research.

Ipamorelin is a synthetic pentapeptide growth hormone-releasing peptide (GHRP), developed as the most selective ghrelin receptor (GHS-R1a) agonist for targeted growth hormone (GH) regulation research:

Core Mechanism & Key Properties

High-affinity, selective binding to GHS-R1a receptors on anterior pituitary somatotroph cells, stimulating physiological pulsatile GH release
Unmatched selectivity: Unlike older generation GHRPs (GHRP-2, GHRP-6), it does not stimulate off-target secretion of ACTH, cortisol, prolactin, or ghrelin-mediated appetite, eliminating non-specific hormonal side effects
Produces GH release kinetics that closely mimic natural endogenous GH secretion, preserving pituitary negative feedback regulation
The gold-standard GHRP for synergistic research stacks with GHRH analogs (e.g., CJC-1295), amplifying GH secretion via complementary pituitary receptor pathways

Primary Research Applications

Growth hormone secretion and pituitary endocrine function studies
Body composition modulation (muscle anabolism, fat loss) research
Exercise recovery and soft tissue regenerative medicine models
Investigations of selective GH stimulation without off-target hormonal disruption

Manufactured to ≥99% purity, sterile-filtered, and lyophilized for long-term storage stability.

For laboratory research use only; not intended for human or veterinary administration.

Research use only: This material is supplied for laboratory research and documentation workflows only. It is not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.

Hytan procurement and documentation support

For Ipamorelin, Hytan Peptides can support research-use sourcing review with available batch COA, vial labeling, product identity notes, storage documentation and wholesale quantity discussion. Product-specific CAS, sequence, molecular weight or method details should be confirmed against the current batch document before procurement decisions.

COA review: request batch-specific purity and identity references where available.
Wholesale planning: confirm vial strength, quantity, lead time, packing and destination requirements.
Compliance: research-use wording should remain clear in quote, invoice and receiving records.

Manufacturing Capability

Controlled production for consistent research peptide supply

Hytan Peptides supports wholesale research peptide orders with organized production workflow, clean handling, standardized filling, labeling and batch-level documentation. From material preparation to final review, each step is managed to support consistent appearance, traceable COA records and dependable supply coordination.

This production overview helps laboratories, distributors and qualified research buyers understand how Hytan Peptides approaches quality-focused peptide manufacturing, packaging and order readiness.